Franken Lotte C, Roos Eva, Saris Job, van Hooft Jeanin E, van Delden Otto M, Verheij Joanne, Erdmann Joris I, Besselink Marc G, Busch Olivier R, van Tienhoven Geertjan, van Gulik Thomas M
Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.
Department of Gastroenterology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.
World J Hepatol. 2020 Nov 27;12(11):1089-1097. doi: 10.4254/wjh.v12.i11.1089.
Preoperative biliary drainage in patients with presumed resectable perihilar cholangiocarcinoma (PHC) is hypothesized to promote the occurrence of seeding metastases. Seeding metastases can occur at the surgical scars or at the site of postoperative drains, and in case of percutaneous biliary drainage, at the catheter port-site. To prevent seeding metastases after resection, we routinely treated PHC patients with preoperative radiotherapy (RT) for over 25 years until January 2018.
To investigate the incidence of seeding metastases following resection of PHC.
All patients who underwent resection for pathology proven PHC between January 2000 and March 2019 were included in this retrospective study. Between 2000-January 2018, patients received preoperative RT (3 × 3.5 Gray). RT was omitted in patients treated after January 2018.
A total of 171 patients underwent resection for PHC between January 2000 and March 2019. Of 171 patients undergoing resection, 111 patients (65%) were treated with preoperative RT. Intraoperative bile cytology showed no difference in the presence of viable tumor cells in bile of patients undergoing preoperative RT or not. Overall, two patients (1.2%) with seeding metastases were identified, both in the laparotomy scar and both after preoperative RT (one patient with endoscopic and the other with percutaneous and endoscopic biliary drainage).
The incidence of seeding metastases in patients with resected PHC in our series was low (1.2%). This low incidence and the inability of providing evidence that preoperative low-dose RT prevents seeding metastases, has led us to discontinue preoperative RT in patients with resectable PHC in our center.
对于拟行可切除的肝门部胆管癌(PHC)患者,术前胆道引流被认为会促进种植转移的发生。种植转移可发生于手术切口或术后引流部位,若行经皮胆道引流,则可发生于导管穿刺部位。为防止切除术后发生种植转移,在2018年1月之前的25年多时间里,我们对PHC患者常规进行术前放疗(RT)。
研究PHC切除术后种植转移的发生率。
本回顾性研究纳入了2000年1月至2019年3月间因病理证实为PHC而接受手术切除的所有患者。2000年1月至2018年1月期间,患者接受术前放疗(3×3.5格雷)。2018年1月之后接受治疗的患者未进行放疗。
2000年1月至2019年3月间,共有171例患者因PHC接受了手术切除。在171例接受手术切除的患者中,11例(65%)接受了术前放疗。术中胆汁细胞学检查显示,接受术前放疗和未接受术前放疗患者的胆汁中存活肿瘤细胞的存在情况无差异。总体而言,共发现2例(1.2%)发生种植转移的患者,均位于剖腹手术切口处,且均在术前放疗后(1例患者接受内镜下和另1例患者接受经皮及内镜下胆道引流)。
在我们的系列研究中,接受手术切除的PHC患者种植转移的发生率较低(1.2%)。鉴于这一低发生率以及无法提供证据表明术前低剂量放疗可预防种植转移,我们中心已停止对可切除PHC患者进行术前放疗。